Search PDMR transactions

Notifier
Name of person with notification obligation
Quantass ApS
Reason for notification
Closely associated
Yes
Person discharging managerial responsibilities
Jeppe Øvli Øvlesen
Position
Chief Executive Officer (CEO)/Managing Directory
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
SynAct Pharma AB
Issuer´s LEI code
549300RRYIEFEQ72N546
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Share SynAct Pharma AB SE0008241491 Acquisition 7,900 Quantity 17.99311139 SEK 05/03/2026 NASDAQ STOCKHOLM AB
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
SynAct Pharma AB SE0008241491 Acquisition 05/03/2026 NASDAQ STOCKHOLM AB 7,900 (Quantity) 17.99311139 SEK
Total: 7,900
<< Back